OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to Gefitinib in a lung adenocarcinomaresistant cell line
Masafumi Noguchi, Susumu Kohno, Anna Pellattiero, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 16

Showing 16 citing articles:

Mitochondrial dynamics in health and disease: mechanisms and potential targets
Wen Chen, Huakan Zhao, Yongsheng Li
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 364

The interplay between mitochondrial dynamics and autophagy: From a key homeostatic mechanism to a driver of pathology
Alice Lacombe, Luca Scorrano
Seminars in Cell and Developmental Biology (2024) Vol. 161-162, pp. 1-19
Open Access | Times Cited: 18

OPA1 promotes ferroptosis by augmenting mitochondrial ROS and suppressing an integrated stress response
Felix G. Liang, Fereshteh Zandkarimi, Jae‐Hoon Lee, et al.
Molecular Cell (2024) Vol. 84, Iss. 16, pp. 3098-3114.e6
Closed Access | Times Cited: 14

Optic atrophy 1 mediates muscle differentiation by promoting a metabolic switch via the supercomplex assembly factor SCAF1
Matthew Triolo, Nicole M. Baker, S. C. Agarwal, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109164-109164
Open Access | Times Cited: 4

Systematic omics analysis identifies CCR6 as a therapeutic target to overcome cancer resistance to EGFR inhibitors
Eunji Kwon, Hyuk‐Jin Cha, Haeseung Lee
iScience (2024) Vol. 27, Iss. 4, pp. 109448-109448
Open Access | Times Cited: 4

Mechanisms of Modulation of Mitochondrial Architecture
Juan Pablo Muñoz, Fernanda Luisa Basei, María L. Rojas, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1225-1225
Open Access | Times Cited: 5

Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics
Hui Li, Xinyan Dai, Jun-Fu Zhou, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 11
Closed Access | Times Cited: 1

Mitochondria in Lung Cancer Progression
Masafumi Noguchi, Keiko Iwata, Norihito Shintani, et al.
Current Pharmacology Reports (2024) Vol. 10, Iss. 6, pp. 380-387
Closed Access

Depleting chemoresponsive mitochondrial fission mediator DRP1 does not mitigate sarcoma resistance
Karolina Borankova, Matyas Solny, Mária Krchniaková, et al.
Life Science Alliance (2024) Vol. 8, Iss. 2, pp. e202402870-e202402870
Open Access

Depletion of chemoresponsive mitochondrial fission mediator DRP1 does not mitigate sarcoma resistance
Karolina Borankova, Matyas Solny, Mária Krchniaková, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Survival prediction and analysis of drug-resistance genes in HER2-positive breast cancer
Lin Yang, Songhao Chen, Meixue Wang, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38221-e38221
Open Access

OPA1 deficiency induces mitophagy through PINK1/Parkin pathway during bovine oocytes maturation
Tiancang Han, Yuhan Zhao, Anhui Jiao, et al.
Theriogenology (2024) Vol. 234, pp. 51-63
Closed Access

Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction
Stéphanie Verbeke, Aurélien Bourdon, Mathilde Lafon, et al.
Translational Oncology (2024) Vol. 52, pp. 102236-102236
Closed Access

Page 1

Scroll to top